These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 7857340)

  • 1. Toxicological evaluation of pidotimod.
    Coppi G; Amico-Roxas M; Bertè F; Bussi R; Gnemi P; Harling RJ; Mailland F; Manzardo S; Massey JE; Spencer-Briggs DJ
    Arzneimittelforschung; 1994 Dec; 44(12A):1448-53. PubMed ID: 7857340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of pidotimod in rats and dogs.
    Coppi G; Silingardi S
    Arzneimittelforschung; 1994 Dec; 44(12A):1460-4. PubMed ID: 7857342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. General pharmacology of pidotimod and testing for drug interactions.
    Manzardo S; Falcone A; Pinzetta A; Ieva G; Coppi G
    Arzneimittelforschung; 1994 Dec; 44(12A):1441-7. PubMed ID: 7857339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective effects of pidotimod against experimental bacterial infections in mice.
    Coppi G; Falcone A; Manzardo S
    Arzneimittelforschung; 1994 Dec; 44(12A):1417-21. PubMed ID: 7857334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. General toxicology of the new antitussive moguisteine.
    Cavalletti E; Ceserani R; Sala F; Montaguti P; Tognella S
    Arzneimittelforschung; 1994 Nov; 44(11):1227-33. PubMed ID: 7848336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experimental immunological screening tests on pidotimod.
    Coppi G; Manzardo S
    Arzneimittelforschung; 1994 Dec; 44(12A):1411-6. PubMed ID: 7857333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the efficacy of pidotimod in the exacerbations in patients affected with chronic bronchitis.
    Bisetti A; Ciappi G; Bariffi F; Catena E; Rocco V; Vaccaro L; Grassi V; Scarpazza G; Bertoli L; Cardani A
    Arzneimittelforschung; 1994 Dec; 44(12A):1499-502. PubMed ID: 7857351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genotoxicity testing of pidotimod in vitro and in vivo.
    Adams K; Allen JA; Brooker PC; Henderson L; Jones E; Proudlock RJ; Mailland F; Coppi G
    Arzneimittelforschung; 1994 Dec; 44(12A):1454-9. PubMed ID: 7857341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of pidotimod on the immune and the neuroendocrine system in the aging rat.
    Chiarenza A; Iurato MP; Barbera N; Lempereur L; Cantarella G; Scapagnini U; Scapagnini G; Bernardini R
    Arzneimittelforschung; 1994 Dec; 44(12A):1437-40. PubMed ID: 7857338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and oral bioavailability of pidotimod in humans.
    Mailland F; Coppi G; Silingardi S
    Arzneimittelforschung; 1994 Dec; 44(12A):1465-9. PubMed ID: 7857343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo antiviral effects of pidotimod.
    Dianzani C; Colangelo D; Tonso E; Guidotto S; Viano I
    Arzneimittelforschung; 1994 Dec; 44(12A):1431-3. PubMed ID: 7857337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene expression for interleukin-2 and tumor necrosis factor-alpha in the spleen of old rats under physiological condition and during septic shock. Possible pharmacological modulation.
    Annoni G; Arosio B; Santambrogio D; Cullurà D; Gagliano N; Uslenghi C
    Arzneimittelforschung; 1994 Dec; 44(12A):1433-6. PubMed ID: 7531977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of pidotimod on macrophage functions in methylprednisolone-treated mice.
    Taramelli D; Malabarba MG; Basilico N; Sala G; Mattina R; Cocuzza C
    Arzneimittelforschung; 1994 Dec; 44(12A):1425-30. PubMed ID: 7857336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunomodulating activity of pidotimod.
    Migliorati G; Nicoletti I; Riccardi C
    Arzneimittelforschung; 1994 Dec; 44(12A):1421-4. PubMed ID: 7857335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pidotimod in the management of recurrent pharyngotonsillar infections in childhood.
    Passali D; Calearo C; Conticello S
    Arzneimittelforschung; 1994 Dec; 44(12A):1511-6. PubMed ID: 7857354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of pidotimod in elderly volunteers and in renal failure patients.
    Spotti D; Biffi M; Coppi G; Silingardi S; Mailland F
    Arzneimittelforschung; 1994 Dec; 44(12A):1470-2. PubMed ID: 7857344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ex vivo evaluation of pidotimod activity in patients with chronic obstructive pulmonary disease.
    Benetti GP; Illeni MT; Passera A; Bombelli G; Lavecchia G; Uslenghi C
    Arzneimittelforschung; 1994 Dec; 44(12A):1503-5. PubMed ID: 7857352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of food on the bioavailability of pidotimod in healthy volunteers.
    D'Angelo L; De Ponti F; Crema F; Caravaggi M; Crema A
    Arzneimittelforschung; 1994 Dec; 44(12A):1473-5. PubMed ID: 7857345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pidotimod activity against chronic bronchitis exacerbations.
    Ciaccia A
    Arzneimittelforschung; 1994 Dec; 44(12A):1516-20. PubMed ID: 7857355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of immunoactivation with pidotimod in recurrent respiratory infections in childhood.
    Careddu P
    Arzneimittelforschung; 1994 Dec; 44(12A):1506-11. PubMed ID: 7857353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.